Biotech · Private company · South San Francisco, CA, US
Gryphon Bio, Inc.
Track this companyFree. Adds Gryphon Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of Novel sgp130-Fc Bioconjugates for TBIFiscal year 2026 · $1.2MNIH RePORTER 5R44NS130780-03 · fetched Nov 12, 2026
- Development of Novel sgp130-Fc Bioconjugates for TBIFiscal year 2025 · $1.2MNIH RePORTER 4R44NS130780-02 · fetched Nov 12, 2026